Oral contraceptives and bone metabolism

Area of Science:

• Bone metabolism and endocrinology
• Reproductive health and bone density

Background:

• Bone metabolism in women is significantly influenced by gonadal steroids and their fluctuations.
• Estrogens play a crucial role in bone remodeling through endocrine and paracrine pathways.

Purpose of the Study:

• To evaluate the effects of oral contraceptives on bone metabolism in various female populations.
• To determine the safety and efficacy of oral contraceptives in preventing bone loss and maintaining bone mineral density.

Main Methods:

• Review of studies on oral contraceptive use in normally cycling women, women with ovulatory disturbances, and those treated with GnRH analogs.
• Analysis of bone mineral density and bone turnover markers in relation to oral contraceptive administration.

Main Results:

• Oral contraceptives do not negatively impact bone mineral density in normally cycling women.
• In women with ovulatory disturbances, oral contraceptives effectively block bone loss and normalize bone mineral density.
• Oral contraceptives counteract GnRH analog-induced bone loss, with the progestogenic component potentially contributing to bone protection.

Conclusions:

• Oral contraceptives are safe for bone maintenance in adult women.
• Oral contraceptives are indicated for preventing postmenopausal osteoporosis, especially in women with ovulatory disturbances.